# Effectiveness of E-prf Alone and in Combination With Bioactive Glass Nanoparticles in Grade II Furcation Defects

> **NCT07042204** · NA · COMPLETED · sponsor: **Merna Nasser Mohamed Mostafa Ibrahim Elnahas** · enrollment: 30 (actual)

## Conditions studied

- Furcation Defects

## Interventions

- **PROCEDURE:** Group I (extended platelet-rich fibrin)
- **PROCEDURE:** Group II (bioactive glass nanoparticles mixed with extended platelet-rich fibrin)
- **PROCEDURE:** Group III (bioactive glass nanoparticles and covered by a collagen membrane)

## Key facts

- **NCT ID:** NCT07042204
- **Lead sponsor:** Merna Nasser Mohamed Mostafa Ibrahim Elnahas
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-01-03
- **Primary completion:** 2025-06-03
- **Final completion:** 2025-08-03
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2026-01-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07042204

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07042204, "Effectiveness of E-prf Alone and in Combination With Bioactive Glass Nanoparticles in Grade II Furcation Defects". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07042204. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*